Investor Presentation • Aug 6, 2025
Investor Presentation
Open in ViewerOpens in native device viewer
Elad Aharonson | President and CEO August 6, 2025
This presentation contains statements that constitute "forward-looking statements," many of which can be identified by the use of forward-looking words such as "anticipate," "believe," "could," "expect," "should," "plan," "intend," "estimate," "strive," "forecast," "targets" and "potential," among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements. Forward-looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding the company intent, belief or current expectations. Forward-looking statements are based on the company management's beliefs and assumptions and on information currently available to the company management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to: changes in exchange rates or prices compared to those we are currently experiencing; the effects of the ongoing security situation in Israel, including the nature and duration of related conflicts; loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and the company reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to harvest salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at the company seaport shipping facilities or regulatory restrictions affecting the company ability to export the company products overseas; general market, political or economic conditions in the countries in which the company operates, including tariffs and trade policies; price increases or shortages with respect to the company principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the company plants; labor disputes, slowdowns and strikes involving the company employees; pension and health insurance liabilities; disruptions from pandemics that may impact the company sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in the company evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of the company, or the company service providers', information technology systems or breaches of the company, or the company service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the company cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the company businesses; changes in demand for the company fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond the company control; sales of the company magnesium products being affected by various factors that are not within the company control; the company ability to secure approvals and permits from the authorities in Israel to continue the company phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of the company workers and processes; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; including the current state of war declared in Israel and any resulting disruptions to the company supply and production chains; filing of class actions and derivative actions against the company, its executives and Board members; the company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under "Item 3 - Key Information— D. Risk Factors" in the company's Annual Report on Form 20-F for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the SEC) on March 13, 2025, (the Annual Report). Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. Investors are cautioned to consider these risks and uncertainties and to not place undue reliance on such information. Forward-looking statements should not be read as a guarantee of future performance or results and are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements. This presentation for the second quarter of 2025 (the Quarterly Report) should be read in conjunction with the Annual Report of 2024 as of and for the year ended December 31, 2024, published by the company on Form 20-F and the published report for the first quarter of 2025 (the prior quarterly report), including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the U.S. SEC. 2

(1) Adjusted EBITDA, specialties-driven EBITDA, and adjusted diluted EPS are non-GAAP financial measures; see reconciliation tables in appendix. Note: Specialties-driven sales and EBITDA includes Industrial Products, Phosphate Solutions and Growing Solutions; see appendix for additional details.


Note: Segment EBITDA and margin are non-GAAP financial measures; please see appendix for additional details.


Note: Segment EBITDA and margin are non-GAAP financial measures; please see appendix for additional details.


Notes: Segment EBITDA and margin are non-GAAP financial measures; please see appendix for additional details. For 2Q'25, Phosphate Specialties comprised \$336M of segment sales, \$39M of OI, \$12M of D&A and represented \$51M of EBITDA, while Phosphate Commodities comprised \$301M of segment sales, \$51M of OI, \$32M of D&A and represented \$83M of EBITDA. 6

Note: Segment EBITDA and margin are non-GAAP financial measures; please see appendix for additional details.

Financial Results
A v i r a m L a h a v
CFO


Sources: Inflation and interest rates – Bloomberg, as of 7.17.25. Global industrial production – CRU, as of June 2025. U.S. housing starts – Bloomberg, as of 7.21.25

Relevant for Potash, Growing Solutions and Phosphate Commodities


Sources: Grain Price Index – CRU, as of 7.3.25. Farmer sentiment – Purdue/CME Ag Economy Barometer, as of 7.8.25. gMOP (US\$/st) and phosphoric acid (US\$/ton) – CRU, as of 7.17.25. Supramax – Hudson Shipping, as of 7.8.25. 10

Relevant for Industrial Products and Phosphate Specialties


Sources: Chinese bromine prices – Bloomberg, as of 7.31.25. Phosphate and sulfur: P2O5 phosphoric acid (US\$/ton) and sulfur FOB Middle East monthly contract (US\$/ton) – CRU, both as of 7.17.25. U.S. durable goods from Real Personal Consumption Expenditures: Durable Goods – U.S. Bureau of Economic Analysis via Federal Reserve Bank of St. Louis, as of 6.27.25. U.S. retail trade and food sales from Advance Retail Sales: Retail Trade and Food Services – U.S. Census Bureau via Federal Reserve Bank of St. Louis, as of 7.17.25.

Sales bridge


Notes: Numbers rounded to closest million; Other includes intercompany eliminations.
Profit bridge


(1) Adjusted EBITDA is a non-GAAP financial measure; please see reconciliation tables in appendix. Notes: Numbers rounded to closest million; Other includes intercompany eliminations.
In cost, quality and price


14
Potash sources: Cost curve – data shown for 2024 and used with permission of CRU International Ltd. 2025, all rights reserved. Potash peers' ASP from company reports, as of 8.6.25. Bromine sources: Bromine concentration – internal calculations; cost curve – Weizmann Institute of Science.
Distinctive global presence

Note: Sales by business exclude other activities and reconciliations of (\$47M). Totals may not sum to 100%, due to rounding and set-offs.

Cash resources \$1.5B available
Net debt to adjusted EBITDA 1.5X
Cash flow Operating cash flow of ~\$269M
Extended & expanded debt offering
Past 2030, with successful ~\$235M fundraising
S&P reaffirmed BBB- rating with stable outlook
Global exchange rates NIS continued to strengthen vs. USD
Shareholder return Quarterly dividend of \$55M Annual yield of 2.6%
Capital allocation Consistent and disciplined execution
Cost savings Targeted efficiency efforts
16
Notes: Available cash resources, as of 6.30.25, and comprised of cash and deposits, unutilized revolving credit facility, and unutilized securitization. Net debt to adjusted EBITDA, as of 6.30.25, is a non-GAAP financial measure; see appendix for additional details. Dividend yield, as of 6.30.25, shown on TTM basis and calculated by summing dividends paid per share for past four quarters, divided by price per share on final trading day of quarter.

Full Year 2025
Full year 2025
Maintaining specialties-driven EBITDA(1)of \$0.95B to \$1.15B
Updating Potash sales volumes to between 4.3M mt and 4.5M mt
Expect annual tax rate of approximately 30%
(1) Specialties-driven EBITDA includes Industrial Products, Phosphate Solutions and Growing Solutions and is a non-GAAP measure; please see appendix for additional details.




| Industrial Products US\$M | 2Q'24 | 2Q'25 |
|---|---|---|
| Segment sales | \$315 | \$319 |
| Segment operating income | \$60 | \$54 |
| Segment operating margin | 19% | 17% |
| Depreciation and amortization | \$14 | \$15 |
| Segment EBITDA | \$74 | \$69 |
| Segment EBITDA margin | 23% | 22% |
| Potash US\$M | 2Q24 | 2Q'25 |
|---|---|---|
| Segment sales | \$422 | \$383 |
| Segment operating income | \$60 | \$52 |
| Segment operating margin | 14% | 14% |
| Depreciation and amortization | \$58 | \$63 |
| Segment EBITDA | \$118 | \$115 |
| Segment EBITDA margin | 28% | 30% |
| Phosphate Solutions(1) US\$M |
2Q'24 | 2Q'25 |
|---|---|---|
| Segment sales | \$572 | \$637 |
| Segment operating income | \$93 | \$90 |
| Segment operating margin | 16% | 14% |
| Depreciation and amortization | \$53 | \$44 |
| Segment EBITDA | \$146 | \$134 |
| Segment EBITDA margin | 26% | 21% |
| Growing Solutions US\$M |
2Q'24 | 2Q'25 |
|---|---|---|
| Segment sales | \$494 | \$540 |
| Segment operating income | \$25 | \$35 |
| Segment operating margin | 5% | 6% |
| Depreciation and amortization | \$20 | \$21 |
| Segment EBITDA | \$45 | \$56 |
| Segment EBITDA margin | 9% | 10% |
(1) For 2Q'25, Phosphate Specialties comprised \$336M of segment sales, \$39M of OI, \$12M of D&A and represented \$51M of EBITDA, while Phosphate Commodities comprised \$301M of segment sales, \$51M of OI, \$32M of D&A and represented \$83M of EBITDA. Note: Numbers may not add, due to rounding and set-offs.


| Segment Sales US\$M |
Industrial Products |
Potash | Phosphate Solutions(1) |
Growing Solutions |
|---|---|---|---|---|
| 2Q'24 | \$315 | \$422 | \$572 | \$494 |
| Quantity | (\$19) | (\$65) | \$34 | \$9 |
| Price | \$19 | \$19 | \$23 | \$36 |
| Exchange rates | \$4 | \$7 | \$8 | \$1 |
| 2Q'25 | \$319 | \$383 | \$637 | \$540 |
| Segment EBITDA US\$M |
Industrial Products |
Potash | Phosphate Solutions(1) |
Growing Solutions |
|---|---|---|---|---|
| 2Q'24 | \$74 | \$118 | \$146 | \$45 |
| Quantity | (\$6) | (\$19) | \$8 | \$5 |
| Price | \$19 | \$19 | \$23 | \$36 |
| Exchange rates | - | \$1 | \$4 | - |
| Raw materials | \$2 | - | (\$23) | (\$23) |
| Energy | (\$1) | - | (\$2) | \$5 |
| Transportation | (\$3) | \$7 | \$6 | (\$1) |
| Operating, other expenses | (\$16) | (\$11) | (\$28) | (\$11) |
| 2Q'25 | \$69 | \$115 | \$134 | \$56 |

Calculation of adjustments for second quarter 2025
| Adjusted EBITDA US\$M |
2Q'24 | 2Q'25 |
|---|---|---|
| Net income | \$130 | \$108 |
| Financing expenses, net | \$33 | \$13 |
| Taxes on income | \$48 | \$60 |
| Less: Share in earnings of equity accounted investees |
- | - |
| Operating income | \$211 | \$181 |
| Depreciation and amortization | \$152 | \$150 |
| Adjustments(1) | \$14 | \$20 |
| Adjusted EBITDA | \$377 | \$351 |
| Free cash flow US\$M |
2Q'24 | 2Q'25 |
| Cash flow from operations | \$316 | \$269 |
| Additions to PP&E, intangible assets and dividends from equity-accounted investees(2) |
(\$141) | (\$199) |
| Free cash flow | \$175 | \$70 |
| Adjusted NI and diluted EPS US\$M, ex. per share |
2Q'24 | 2Q'25 |
|---|---|---|
| Net income, attributable | \$115 | \$93 |
| Adjustments(1) | \$14 | \$20 |
| Total tax adjustments | (\$3) | (\$3) |
| Adjusted net income, attributable | \$126 | \$110 |
| Weighted-average number of diluted ordinary shares outstanding in millions |
1,290 | 1,292 |
| Adjusted diluted EPS | \$0.10 | \$0.09 |
| Net debt to adjusted EBITDA(3) US\$M |
2Q'25 | |
| Net debt | \$2,032 | |
| Adjusted EBITDA | \$1,385 |
Net debt to adjusted EBITDA 1.5
(1) See adjustments to reported operating and net income (non-GAAP) in corresponding quarters' earnings release. (2) Also includes proceeds from sale of property, plant & equipment (PP&E). (3) Calculated by dividing net debt, without securitization, by past four quarters adjusted EBITDA. Note: Numbers may not add, due to rounding & set-offs. 24

Guidance: The company only provides guidance on a non-GAAP basis. The company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. The company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The company provides guidance for specialties-driven EBITDA, which includes Industrial Products, Growing Solutions and Phosphate Solutions. For the Potash business, the company provides sales volume guidance.
Non-GAAP financial measures: The company discloses in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Management uses adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, free cash flow and adjusted EBITDA to facilitate operating performance comparisons from period to period. The company calculates adjusted operating income by adjusting operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" in the appendix. Certain of these items may recur. The company calculates adjusted net income attributable to the company's shareholders by adjusting net income attributable to the company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" in the appendix, excluding the total tax impact of such adjustments. The company calculates diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Free cash flow is calculated as cash flow from operations less any additions to PP&E, intangible assets, and dividends from equity-accounted investees. Adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under "Consolidated adjusted EBITDA, and diluted adjusted earnings per share for the periods of activity" in the appendix, which were adjusted for in calculating the adjusted operating income.
You should not view adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the company's shareholders determined in accordance with IFRS, and you should note that the company's definitions of adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of the company's non-IFRS financial measures as tools for comparison. However, the company believes adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of ongoing operations. Management uses these non-IFRS measures to evaluate the company's business strategies and management performance. The company believes these non-IFRS measures provide useful information to investors because they improve the comparability of financial results between periods and provide for greater transparency of key measures used to evaluate performance.
The company presents a discussion in the period-to-period comparisons of the primary drivers of change in the company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on the company's businesses. The company has based the following discussion on its financial statements. You should read such discussion together with the company's financial statements.
Have a question? We'll get back to you promptly.